Table 4.
Enthesitis | Dactylitis | |||||||
---|---|---|---|---|---|---|---|---|
Secukinumab 300 mg (%) | Secukinumab 150 mg (%) | Secukinumab 75 mg (%) | Placebo (%) | Secukinumab 300 mg (%) | Secukinumab 150 mg (%) | Secukinumab 75 mg (%) | Placebo (%) | |
FUTURE-1 | – | 46.0 | 48.8 | 12.8 | – | 48.8 | 56.7 | 15.5 |
FUTURE-2 | 48.2 | 42.2 | 32.4 | 21.5 | 56.5 | 50 | 30.3 | 14.8 |